Literature DB >> 12902062

Peripheral lung adenocarcinomas: 10 mm or less in diameter.

Daizo Kondo1, Katsuo Yamada, Yasuhiko Kitayama, Shoji Hoshi.   

Abstract

BACKGROUND: Few reports have been published regarding peripheral lung adenocarcinomas that are 10 mm or less in diameter. This is considered to be the smallest tumor size detectable by present diagnostic modalities.
METHODS: Clinicopathologic studies were performed in 57 patients with peripheral lung adenocarcinomas of 10 mm or less in diameter. Outcomes were compared with two other groups that consisted of 32 patients with adenocarcinomas between 11 and 15 mm in diameter and 35 patients with adenocarcinomas between 16 and 20 mm in diameter. Tumors were curatively resected between 1992 and 2002.
RESULTS: The mean age was 61.7 years. The following three features were more frequent: female sex (78.9%), nonsmokers (77.2%), and cases with carcinoma detected by computed tomography despite negative chest radiography (96.5%). Negative lymphatic invasion (94.7%) was significantly higher. Three cases showed lymphatic invasion that was classified as types E or F, according to Noguchi's classification. There were no cases of lymph node metastasis, pleural involvement, or intrapulmonary metastasis. Well-differentiated type was in 93.0%. Types A and B, which are noninvasive alveolar replacement-type adenocarcinomas, were significantly dominant (86.0%). The 5-year postoperative survival rate was 97.3%, which was significantly better than in the other two groups (75.5%, 78.1%).
CONCLUSIONS: Histopathologic features of most peripheral lung adenocarcinomas of 10 mm or less in diameter were types A and B. Types A and B were considered fundamentally indicated for thoracoscopic wedge resections. However, the other types required the standard operation.

Entities:  

Mesh:

Year:  2003        PMID: 12902062     DOI: 10.1016/s0003-4975(03)00340-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  A decade of advances in treatment of early-stage lung cancer.

Authors:  Luca Paoletti; Nicholas J Pastis; Chadrick E Denlinger; Gerard A Silvestri
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

2.  A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.

Authors:  Chun-Lei Shi; Xue-Yan Zhang; Bao-Hui Han; Wei-Zhong He; Jie Shen; Tian-Qing Chu
Journal:  Med Oncol       Date:  2010-07-27       Impact factor: 3.064

3.  Surgical outcomes of lung cancer measuring less than 1 cm in diameter.

Authors:  Daisuke Hamatake; Yasuhiro Yoshida; So Miyahara; Shin-ichi Yamashita; Takeshi Shiraishi; Akinori Iwasaki
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-08-17

4.  Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.

Authors:  Zhenfa Zhang; Anlei Wang; Bingsheng Sun; Zhongli Zhan; Kexin Chen; Changli Wang
Journal:  J Cardiothorac Surg       Date:  2013-04-16       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.